Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Herpes Simplex Virus Type 2 (HSV-2) virion is a complex, enveloped viral particle responsible for causing genital herpes and other infections. Its structure comprises a dsDNA genome enclosed within an icosahedral capsid, surrounded by a tegument layer containing various regulatory proteins, and an outer envelope studded with viral glycoproteins essential for cell entry. The virion's architecture facilitates protection of the genetic material, cell invasion, and immune modulation.
Antiviral drugs typically target viral DNA polymerase, inhibiting viral DNA replication. Some drugs may interfere with viral entry or other stages of the viral life cycle.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes Simplex Virus Type 2 Virion (HSV-2 Virion).